You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PEG2000

Showing 1 - 25 of 171
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anaphylactic Reaction, Vaccine Reaction Trial in Paris (COVID-19 Vaccines)

Recruiting
  • Anaphylactic Reaction
  • Vaccine Reaction
  • COVID-19 Vaccines
  • Paris, France
    Tenon Hospital APHP dermatology and allergology department
Oct 15, 2021

Colonoscopy Trial in Chendu (100 ml lactulose combined with 1 L PEG, 100 ml lactulose combined with 2 L PEG, 200 ml lactulose)

Completed
  • Colonoscopy
  • 100 ml lactulose combined with 1 L PEG
  • +3 more
  • Chendu, Sichuan, China
    west china fourth hospital of Sichuan university
Dec 29, 2022

COVID-19, COVID-19 Immunisation Trial in United States (mRNA-1273, mRNA-1273.351)

Active, not recruiting
  • COVID-19
  • COVID-19 Immunisation
  • mRNA-1273
  • mRNA-1273.351
  • Decatur, Georgia
  • +3 more
Aug 11, 2022

Mental Fatigue Created by Social Media on Upper Extremity

Completed
  • Mental Fatigue
  • +2 more
  • Social Media Fatigue
  • Balıkesir, Turkey
    Bandirma Onyedi Eylul University
Oct 12, 2023

Bowel Preparation Before Colonoscopy Trial in Wuhan (PEG+lactulose, CSP+lactulose)

Recruiting
  • Bowel Preparation Before Colonoscopy
  • Wuhan, Hubei, China
    Renmin Hospital of Wuhan University
Aug 24, 2022

Acute Lymphocytic Leukemia, Adult Lymphoblastic Lymphoma Trial in United States (DNR, VCR, PEG-asp)

Terminated
  • Acute Lymphocytic Leukemia
  • Adult Lymphoblastic Lymphoma
  • La Jolla, California
  • +3 more
Apr 26, 2022

Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission Trial in São Paulo (Bortezomib)

Not yet recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • Acute Lymphoblastic Leukemia With Failed Remission
  • São Paulo, SP, Brazil
    Instituto do Cancer do Estado de Sao Paulo
Sep 12, 2023

Chronic Hepatitis B Trial in Beijing (PEG-IFN)

Recruiting
  • Chronic Hepatitis B
  • Beijing, Beijing, China
    Department of Hepatology Division 2, Beijing Ditan Hospital
May 9, 2022

Chronic Hepatitis B Trial in Zhengzhou (continuous treatment, pulse therapy)

Recruiting
  • Chronic Hepatitis B
  • continuous treatment
  • pulse therapy
  • Zhengzhou, Henan, China
    Henan Provincial People's Hospital
Jul 13, 2022

Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Miami (Pevonedistat, Vincristine,

Completed
  • Refractory Acute Lymphoblastic Leukemia
  • Relapsed Acute Lymphoblastic Leukemia
  • Miami, Florida
    University of Miami
Oct 19, 2022

Leukemia, Leukemia, Acute, Leukemia, Lymphoblastic Trial in Guangzhou (Chidamide, Dasatinib)

Recruiting
  • Leukemia
  • +3 more
  • Guangzhou, Guangdong, China
    Department of Hematology, Nanfang Hospital
Jun 28, 2022

Acute Lymphoid Leukemia, Minimal Residual Disease, Gene Abnormality Trial in São Paulo (Prednisone, Vincristin, Daunorubicin)

Recruiting
  • Acute Lymphoid Leukemia
  • +3 more
  • São Paulo, SP, Brazil
    Instituto do Cancer do Estado de Sao Paulo
Jul 24, 2023

Chronic Hepatitis B Trial in Shanghai (Hepalatide, Placebo of Hepalatide, Tenofovir Alafenamide Tablets)

Not yet recruiting
  • Chronic Hepatitis B
  • Shanghai, Shanghai, China
  • +1 more
Feb 16, 2022

Bowel Preparation for Colonoscopy Trial in Shanghai (Oral sulfate solution (OSS), Polyethylene Glycol Electrolyte)

Completed
  • Bowel Preparation for Colonoscopy
  • Oral sulfate solution (OSS)
  • Polyethylene Glycol Electrolyte
  • Shanghai, China
    Changhai Hospital
Jul 23, 2022

Solid Tumor Malignancy, Hematologic Malignancy, Leukemia Trial run by the NCI (mrna 1273 injection)

Recruiting
  • Solid Tumor Malignancy
  • +4 more
  • mRNA-1273
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 14, 2023

COVID-19, SARS-CoV-2 Trial in Indonesia, Mexico (SARS-CoV-2 mRNA Vaccine, Placebo)

Recruiting
  • COVID-19
  • SARS-CoV-2
  • SARS-CoV-2 mRNA Vaccine
  • Placebo
  • Jakarta, Indonesia
  • +11 more
Nov 10, 2021

COVID-19, COVID-19 Immunisation Trial in Decatur, Bethesda, Seattle (mRNA-1273)

Completed
  • COVID-19
  • COVID-19 Immunisation
  • mRNA-1273
  • Decatur, Georgia
  • +2 more
Jan 26, 2023

Melanoma Trial in Napoli (Vemurafenib, Peg-interferon, Cobimetinib)

Completed
  • Melanoma
  • Napoli, Italy
    Fondazione G.Pascale
Feb 23, 2022

Lymphoblastic Lymphoma Trial in Chengdu, Shanghai (Prednisone,Vincristine, Pegylated-asparaginase, Cytarabine, Cyclophosphamide,

Active, not recruiting
  • Lymphoblastic Lymphoma
  • Prednisone,Vincristine, Pegylated-asparaginase, Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine
  • +6 more
  • Chengdu, China
  • +1 more
Mar 17, 2022

Stroke Trial in Punta Arenas (Training with Robotic Hand Exoskeleton)

Completed
  • Stroke
  • Training with Robotic Hand Exoskeleton
  • Punta Arenas, XII Región, Chile
    Corporación de Rehabilitación Club de Leones Cruz del Sur
Oct 27, 2022

HIV Trial in United States (Peginterferon alfa-2b)

Completed
  • HIV Infections
  • Peginterferon alfa-2b
  • Long Beach, California
  • +14 more
Oct 28, 2021

Hepatitis B, Chronic Trial in Shanghai (hepalatide, Pegylated Interferon, TAF)

Not yet recruiting
  • Hepatitis B, Chronic
  • Shanghai, Shanghai, China
    Shanghai Tong Ren Hospital
Nov 12, 2021

Lymphoblastic Leukemia, Acute, Adult, Ph Negative ALL, Newly Diagnosed Trial in Czechia (Blinatumomab)

Active, not recruiting
  • Lymphoblastic Leukemia, Acute, Adult
  • +2 more
  • Brno, Czechia
  • +4 more
Aug 3, 2022

Friedreich Ataxia, Neuro-Degenerative Disease Trial in Worldwide

Recruiting
  • Friedreich Ataxia
  • Neuro-Degenerative Disease
    • Los Angeles, California
    • +13 more
    Jan 19, 2023

    Chronic Hepatitis B Trial in Zhengzhou (PegIFN a- 2b)

    Completed
    • Chronic Hepatitis B
    • PegIFN α- 2b
    • Zhengzhou, Henan, China
      Henan Provincial People's Hospital
    Jul 11, 2022